SG/PUT/NOVO-NORDISK B/900/0.1/19.12.25 Share Price

Warrant

DE000SW981Y4

Market Closed - Bid/Ask 18:46:39 03/07/2024 BST After market 19:39:19
1.66 EUR +7.79% Intraday chart for SG/PUT/NOVO-NORDISK B/900/0.1/19.12.25 1.69 +1.81%
Current month+1.32%
1 month-19.79%
Date Price Change
03/07/24 1.66 +7.79%
02/07/24 1.54 +5.48%
01/07/24 1.46 -3.95%
28/06/24 1.52 +2.01%
27/06/24 1.49 +0.68%

Real-time Boerse Frankfurt Warrants

Last update July 03, 2024 at 06:46 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SW981Y
ISINDE000SW981Y4
Date issued 13/05/2024
Strike 900 kr
Maturity 19/12/2025 (534 Days)
Parity 10 : 1
Emission price 2.23
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 2.15
Lowest since issue 1.39
Delta0x
Omega 0.000000
Premium0x
Gearing7.71x
Moneyness 0.9302
Difference Strike -67.5 kr
Difference Strike %-7.50%
Spread 0.04
Spread %2.35%
Intrinsic value 0.000000
Present value 1.690

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus